Publications
95
Citations
2,771
Est. group size
~3
Recurring co-author estimate
Active years
27
Publishing since 2000
Juan Peng's work spans two main areas: lipid and cardiovascular biology (such as cholesterol-lowering drugs, PCSK9 protein regulation, and atherosclerosis) and Parkinson's disease research using brain imaging to study motor, cognitive, and emotional symptoms. This research could suit students interested in either metabolic/cardiovascular disease mechanisms or neuroimaging studies of neurodegenerative disorders.
Publication output has remained fairly steady over the last decade, generally ranging between 3 and 9 papers per year without a clear upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Association of psoriasis and genetic predisposition for the risk of cardiometabolic diseases: a population-based cohort study
Clinical and Experimental Dermatology · 2025
- Cerebral microbleeds aggravate severity of motor function, cognitive and emotional status in Parkinson’s disease
Acta Neurologica Belgica · 2025
- Constipation is associated with emotional and cognitive impairment in patients with Parkinson’s disease: A clinical and brain functional study
Neuroscience · 2024
- Hybrid Microneedle-Mediated Transdermal Delivery of Atorvastatin Calcium-Loaded Polymeric Micelles for Hyperlipidemia Therapy
ACS Applied Bio Materials · 2024
- A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
Molecular Biomedicine · 2023
- Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
Renal Failure · 2023
- TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression
Experimental Cell Research · 2023
- White matter hyperintensities burden in the frontal regions is positively correlated to the freezing of gait in Parkinson’s disease
Frontiers in Aging Neuroscience · 2023
- Altered connectivity in the cognitive control-related prefrontal cortex in Parkinson’s disease with rapid eye movement sleep behavior disorder
Brain Imaging and Behavior · 2023
- Retraction notice to “Betulinic acid downregulates expression of oxidative stress-induced lipoprotein lipase via PKC/ERK/c-Fos pathways in RAW264.7 macrophages” [Biochimie 119C (2015) 192–203]
Biochimie · 2023
- Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus
Figshare · 2023
- Sars‐Cov‐2 Spike Protein‐Induced Damage of hiPSC‐Derived Cardiomyocytes
Advanced Biology · 2022
- Abnormal connectivity model of raphe nuclei with sensory-associated cortex in Parkinson’s disease with chronic pain
Neurological Sciences · 2022
- Effect of PCSK9 on Vascular Smooth Muscle Cell Functions: A New Player in Atherosclerosis
Current Medicinal Chemistry · 2021
- RESEARCH ON TEACHING, MANAGEMENT AND LEARNING DIFFICULTIES AND SOLUTIONS IN “DATA STRUCTURE AND ALGORITHM” OF APPLIED UNDERGRADUATE
2021
- Psychoneuroendocrinology×5
- Atherosclerosis×2
- Clinica Chimica Acta×2
- Experimental Neurology×2
- International Journal of Molecular Medicine×2
- M. Wesley Milks
Medicine · The Ohio State University
- Michael D. Cressman
Medicine · The Ohio State University
- David Hunt
Medicine · Indiana University
- Kevin C. Maki
Medicine · Indiana University
- Neena Thomas
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile